Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04234646 · ClinicalTrials.gov registry record · NA

Patient Navigation 2.0

A NA study of Cancer, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT04234646 is a NA study of Cancer that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 600 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04234646, a NA study of Cancer, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

This study evaluates whether a "Patient Navigation 2.0 Checklist" intervention is effective in addressing patients' social determinants of health and recommended cancer-related screenings, behavioral counseling, and immunizations.

Conditions Studied

Interventions

  • BEHAVIORAL Patient Navigation (PN) 2.0 Checklist
  • BEHAVIORAL One-on-one Patient Navigation (PN)

Study Locations (1)

Illinois

  • Northwestern - Chicago

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2020-12-09
Est. Completion 2026-07-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04234646

The ClinicalTrials.gov registry entry for NCT04234646 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (83% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient Navigation (PN) 2.0 Checklist is the first listed.

NCT04234646 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04234646 about?

NCT04234646 is a clinical study titled "Patient Navigation 2.0". This study evaluates whether a "Patient Navigation 2.0 Checklist" intervention is effective in addressing patients' social determinants of health and recommended cancer-related screenings, behavioral counseling, and immunizations.

What is the current status of trial NCT04234646?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2020-12-09. Estimated completion is 2026-07-31.

What conditions does trial NCT04234646 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT04234646?

The interventions under investigation include: Patient Navigation (PN) 2.0 Checklist (BEHAVIORAL), One-on-one Patient Navigation (PN) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04234646?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04234646 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.